Press Releases on November 7, 2024 - EIN Presswire - Press Release Distribution Service

Published on November 7, 2024 - 21:05 GMT

LifeVantage to Participate at the Sidoti Micro Cap Conference

SALT LAKE CITY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on November 7, 2024 - 21:05 GMT

Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates

Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral dosing First participants dosed in Phase 1b trial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2024 - 21:05 GMT

AvePoint Announces Third Quarter 2024 Financial Results

Third quarter SaaS revenue of $60.9 million, representing 45% year-over-year growth Third quarter Total revenue of $88.8 million, representing 22% year-over-year growth Total ARR of $308.9 million, representing 23% year-over-year growth JERSEY CITY, N.J., …

Distribution channels: Business & Economy, IT Industry ...

Published on November 7, 2024 - 21:05 GMT

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in investor meetings at the …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 7, 2024 - 21:05 GMT

H&R Block Reports Fiscal 2025 First Quarter Results

— Revenue Increased 5% — — Repurchased $210 Million of Shares — — Reaffirms Full Year Outlook — KANSAS CITY, Mo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the "Company") today released financial results1 for its fiscal …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 7, 2024 - 21:05 GMT

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-end Cash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2024 - 21:05 GMT

Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024

MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- November 7, 2024 (GLOBE NEWSWIRE) – Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on November 7, 2024 - 21:05 GMT

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2024 - 21:05 GMT

Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Topline SVR12 Results from Global Phase 2 Hepatitis C Virus (HCV) Study (N=275) Expected Q4’24 New Data Supportive of HCV Combination to be Presented at the American Association for the Study of Liver Diseases’ (AASLD’s) The Liver Meeting 2024 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2024 - 21:05 GMT

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of ...

Preliminary data demonstrate durable and dose-dependent T cell responses targeting KRAS mutations and induced responses to patient-specific neoantigens Correlation observed between disease-free survival (“DFS”) and T cell response ELI-002 Phase 1 safety …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2024 - 21:05 GMT

Synaptics Reports First Quarter Fiscal 2025 Results

Q1’25 Financial Results and Recent Business Highlights Revenue of $257.7 million GAAP gross margin of 46.9 percent Non-GAAP gross margin of 53.9 percent GAAP loss per share of $0.58 Non-GAAP diluted earnings per share of $0.81 SAN JOSE, Calif., Nov. 07, …

Distribution channels: Business & Economy, Technology ...

Published on November 7, 2024 - 21:05 GMT

RCM Technologies, Inc. Announces Third Quarter Results

PENNSAUKEN, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health …

Distribution channels: Business & Economy ...

Published on November 7, 2024 - 21:05 GMT

Brilliant Earth Reports Third Quarter 2024 Results

Delivered Net Sales Within Guidance Range and Drove 11% Year-Over-Year Repeat Order Growth Increased Third Quarter Gross Margin by 230 bps Year-Over-Year to 60.8% Reported GAAP Diluted EPS of $(0.01) and Adjusted Diluted EPS of $0.02 Exceeded Profitability …

Distribution channels: Business & Economy, Mining Industry ...

Published on November 7, 2024 - 21:05 GMT

LifeMD Reports Third Quarter 2024 Results

Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65% Record gross margin of 90.6%, up 300 basis points from the year-ago period Adjusted EBITDA increased 33% to $3.7 million Telehealth adjusted EBITDA of $2.5 million …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 7, 2024 - 21:05 GMT

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical …

Distribution channels: Business & Economy, Technology ...

Published on November 7, 2024 - 21:05 GMT

Westrock Coffee Company Reports Third Quarter 2024 Results

LITTLE ROCK, Ark., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the third quarter ended September 30, 2024. Scott T. Ford, CEO and Co-founder stated, “ …

Distribution channels: Business & Economy, Companies ...

Published on November 7, 2024 - 21:05 GMT

StepStone Group Reports Second Quarter Fiscal Year 2025 Results

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 7, 2024 - 21:05 GMT

Jamf Releases Third Quarter 2024 Financial Results

MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced financial results for its third quarter ended September 30, 2024, through an earnings release available on the company’ …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 7, 2024 - 21:05 GMT

TELA Bio Reports Third Quarter 2024 Financial Results

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third …

Distribution channels: Business & Economy, Technology ...

Published on November 7, 2024 - 21:05 GMT

The Joint Corp. Reports Third Quarter 2024 Financial Results

SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended September 30, 2024. Financial Highlights: Q3 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...